London Daily

Focus on the big picture.
Thursday, Jul 10, 2025

COVID-19: Delaying second dose of Pfizer jab may leave elderly at risk of catching South African variant, study suggests

COVID-19: Delaying second dose of Pfizer jab may leave elderly at risk of catching South African variant, study suggests

Lab tests showed that one dose of the vaccine may not stimulate the immune system to produce enough antibodies to kill the virus.

Delaying the second dose of the Pfizer jab – the current government strategy - may leave some elderly patients at risk of infection by the South African variant, new research suggests.

Lab tests by scientists at Cambridge University showed that one dose of the vaccine may not stimulate the immune system to produce enough antibodies to kill the virus.

Only after a second dose would antibody levels be protective, according to preliminary data in the study, which has not yet been peer-reviewed.

Meanwhile, the South African variant has a mutation called E484K that helps it evade the immune system.

SOUTH AFRICAN VARIANT CASES



Some samples of the Kent variant have now been detected with the same mutation.

The Cambridge researchers tested blood samples from 26 people, 15 of them over 80, who had received one dose of the Pfizer jab against synthetic versions of both variants.

Antibodies in all volunteers were sufficient to kill the Kent variant.

But when the E484K mutation was added 10 times more antibodies were needed to neutralise the virus.

According to researchers, seven people had antibody levels that were insufficient to kill the virus after one dose of the vaccine, all of them over 80.

Only after a second dose, given three weeks later, were their antibody levels boosted to a level that killed the virus.

The study comes on the day Sky News analysis showed the number of deaths in the second wave of COVID-19 infections has now overtaken the number from the first.

Dr Dami Collier, one of the co-investigators, said: "Our data suggest that a significant proportion of people aged over 80 may not have developed protective neutralising antibodies against infection three weeks after their first dose of the vaccine.

"But it's reassuring to see that after two doses, serum from every individual was able to neutralise the virus."

Professor Ravi Gupta, the lead researcher, said: "Our work suggests the vaccine is likely to be less effective when dealing with this (E484K) mutation.

"B1.1.7 [the Kent variant] will continue to acquire mutations seen in the other variants of concern, so we need to plan for the next generation of vaccines to have modifications to account for new variants.

"We also need to scale up vaccines as fast and as broadly as possible to get transmission down globally."

A Department for Health and Social Care (DHSC) spokesperson said the decision to change vaccine dosage intervals (to spread them further apart) had come after a "thorough review of data" which showed the Pfizer/BioNTech vaccine was 89% effective in protection against COVID between 15 to 21 days after the first dose.

A DHSC statement said today's study had "assessed just one aspect of immunity, on a small cohort" and that getting vaccines deployed as quickly as possible to those at risk remained "our number one priority".

It concluded: "The Government is closely following the guidance of the Joint Committee on Vaccination and Immunisation and the UK's four Chief Medical Officers, which recommends we prioritise first doses of vaccine for as many people as possible"

The E484K variant helps the coronavirus evade the immune system and was found in 11 samples of some 200,000 that have been sequenced.

Sky's science correspondent Thomas Moore said the discovery of the E484K mutation was a "worrying development," as it could reduce the effectiveness of COVID vaccines and could also mean those who had been previously infected could be re-infected.

He said the evolution of E484K meant the virus had effectively "developed a superpower" which enabled it to not only infect cells, but also to beat the immune system.

"It changes shape so antibodies don't recognise it in the same way, and the fact that this mutation has been now picked up in some samples of the Kent variant is a twist - a worrying development," said Thomas Moore.

Newsletter

Related Articles

0:00
0:00
Close
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
US Imposes New Tariffs on Brazilian Exports Amid Political Tensions
Azerbaijan and Armenia are on the brink of a historic peace deal.
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Weinstein Victim’s Lawyer Says MeToo Movement Still Strong
U.S. Enacts Sweeping Tax and Spending Legislation Amid Trade Policy Shifts
Football Mourns as Diogo Jota and Brother André Silva Laid to Rest in Portugal
Labour Expected to Withdraw Support for Special Needs Funding Model
Leaked Audio Reveals Tory Aide Defending DEI Record
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
London Stock Exchange Faces Historic Low in Initial Public Offerings
A new online platform has emerged in the United Kingdom, specifically targeting Muslim men seeking virgin brides
Trump Celebrates Independence Day with B-2 Flyover and Signs Controversial Legislation
Boris Johnson Urges Conservatives to Ignore Farage
SNP Ordered to Update Single-Sex Space Guidance Within Days
Starmer Set to Reject Calls for Wealth Taxes
Stolen Century-Old Rolls-Royce Recovered After Hotel Theft
Macron Presses Starmer to Recognise Palestinian State
Labour Delayed Palestine Action Ban Over Riot Concerns
Swinney’s Tax Comments ‘Offensive to Scots’, Say Tories
High Street Retailers to Enforce Bans on Serial Shoplifters
Music Banned by Henry VIII to Be Performed After 500 Years
Steve Coogan Says Working Class Is Being ‘Ethnically Cleansed’
Home Office Admits Uncertainty Over Visa Overstayer Numbers
JD Vance Questions Mandelson Over Reform Party’s Rising Popularity
Macron to Receive Windsor Carriage Ride in Royal Gesture
Labour Accused of ‘Hammering’ Scots During First Year in Power
BBC Head of Music Stood Down Amid Bob Vylan Controversy
Corbyn Eyes Hard-Left Challenge to Starmer’s Leadership
London Tube Trains Suspended After Major Fire Erupts Nearby
Richard Kemp: I Felt Safer in Israel Under Attack Than in the UK
Cyclist Says Police Cited Human Rights Act for Riding No-Handed
China’s Central Bank Consults European Peers on Low-Rate Strategies
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Musk Battles to Protect Tesla Amid Trump Policy Threats
Air France-KLM Acquires Majority Stake in Scandinavian Airlines
UK Educators Sound Alarm on Declining Child Literacy
Shein Fined €40 Million in France Over Misleading Discounts
Brazil’s Lula Visits Kirchner During Argentina House Arrest
Trump Scores Legislative Win as House Passes Tax Reform Bill
Keir Starmer Faces Criticism After Rocky First Year in Power
DJI Launches Heavy-Duty Coaxial Quadcopter with 80 kg Lift Capacity
U.S. Senate Approves Major Legislation Dubbed the 'Big Beautiful Bill'
Largest Healthcare Fraud Takedown in U.S. History Announced by DOJ
×